Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: A randomized, double-blind, crossover study

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 5, 2013, Pages 1982-1990

  Hoang, Thanh D ^a   Olsen, Cara H ^b   Mai, Vinh Q ^a   Clyde, Patrick W ^a   Shakir, Mohamed K M ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE SODIUM; THYROID EXTRACT;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BIOCHEMISTRY; COGNITION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TERTIARY HEALTH CARE; WELLBEING;

ADULT; AGED; ANIMALS; COGNITION; COGNITION DISORDERS; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; PATIENT PREFERENCE; QUALITY OF LIFE; RECEPTORS, THYROID HORMONE; SEVERITY OF ILLNESS INDEX; THYROID GLAND; THYROID HORMONES; THYROXINE; TISSUE EXTRACTS; WEIGHT LOSS; YOUNG ADULT;

EID: 84877712177     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-4107     Document Type: Article

References (40)

1. Braverman LE, Utiger RD. Introduction to hypothyroidism. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text. 8th ed. Philadelphia, PA: Lippincott Williams, Wilkins; 2000: 755-761.
2. Roberts CG, Ladenson PW. Hypothyroidism. Lancet. 2004;363: 793-803.
3. Cooper DS, Biondi B. Subclinical thyroid disease. Lancet. 2012; 379:1142-1154.
4. Lowe JC. Stability, effectiveness, and safety of desiccated thyroid vs. levothyroxine: a rebuttal to the British Thyroid Association. Thyroid Sci. 2009;4:C1-C12.
5. Wechsler DA. 1997 The Wechsler Memory Scale-III. 3rd ed. San Antonio, TX: Psychological Corp; 1997
6. Benson N, Hulac DM, Kranzler JH. Independent examination of the Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV): what does the WAIS-IV measure? Psychol Assess. 2010;22:121-130.
7. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561- 571.
8. Jaeschke R, Guyatt G, Cook D, Harper S, Gerstein HC. Spectrum of quality of life impairment in hypothyroidism. Qual Life Res. 1994; 3:323-327.
9. Cooper DS, Halpern R, Wood LC, Levin AA, Ridgway EC. L-Thyroxine therapy in subclinical hypothyroidism: a double-blind, placebo-controlled trial. Ann Intern Med. 1984;101:18-24.
10. McDowell I, Newell C. The General Health Questionnaire. Measuring Health. AGuide to Rating Scales and Questionnaires. 2nd ed. New York, NY: Oxford University Press; 1996.
11. Clyde PW, Harari AE, Getka EJ, Shakir KM. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial. JAMA. 2003; 290:2952-2958.
12. United States Pharmacopeia Drug Information: Drug Information for the Health Care Professional. Vol 1. 20th ed. Greenwood Village, CO; 2000.
13. Thompson WO, Thompson PK, Brailey AG, Cohen AC. The calodoi: rigenetic action of thyroxin at different levels of basal metabolism in myxedema. J Clin Invest. 1929;7:437-463.
14. Thompson WO, McLellan LL, Thompson PK, Dickie LF. The rates of utilization of thyroxine and of desiccated thyroid in man: the relation between the iodine in desiccated thyroid and thyroxine. J Clin Invest. 1933;12:235-246.
15. Means JH, Lerman J, Salter WT. The role of thyroxin iodine and total organic iodine in the calorigenic action of whole thyroid gland. J Clin Invest. 1933;12:683-688.
16. Robertson JD, Kirkpatrick HF. Changes in basal metabolism, serum protein-bound iodine and cholesterol during treatment of hypothyroidism with oral thyroid and L-thyroxine sodium. Br Med J. 1952; 1:624-628.
17. Sturnick MI, Falcon-Lesses M. A comparison of the effect of desiccated thyroid and sodium levothyroxine on the serum proteinbound iodine. N Engl J Med. 1961;264:608-609.
18. Jackson IM, Cobb WE. Why does anyone still use desiccated thyroid USP? Am J Med. 1978;64:284-288.
19. Lanni A, Moreno M, Lombardi A, Goglia F. Calorigenic effect of diiodothyronines in the rat. J Physiol. 1996;494:831-837.
20. Smith RN, Taylor SA, Massey JC. Controlled clinical trial of combined triiodothyronine and thyroxine in the treatment of hypothyroidism. Lancet. 1970;4:145-148.
21. Bunevicius R, Prange AJ. Mental improvement after replacement therapy with thyroxine plus triiodothyronine: relationship to cause of hypothyroidism. Int J Neuropsychopharmacol. 2000;3:167-174.
22. Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med. 1999;340:424-429.
23. 4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. J Clin Endocrinol Metab. 2003;88:4551- 4555.
24. Walsh JP, Shiels L, Lim EM, et al. Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab. 2003;88:4543-4550.
25. Escobar-Morreale HF, Botella-Carretero JI, Gómez-Bueno M, Galán JM, Barrios V, Sancho J. Thyroid hormone replacement therapy in primary hypothyroidism: A randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Ann Intern Med. 2005;142:412-424.
26. 4 replacement therapy: results of a large communitybased randomized controlled trial. J Clin Endocrinol Metab. 2005; 90:805-812.
27. Appelhof BC, Fliers E, Wekking EM, et al. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. J Clin Endocrinol Metab. 2005;90:2666.
28. Escobar-Morreale HF; Botella-Carretero JI, Escobar del Rey F, Morreale de Escobar G. Treatment of hypothyroidism with combinations of levothyroxine plus liothyronine. J Clin Endocrinol Metab. 2005;90:4946-4954.
29. Grozinsky-Glasberg S, Fraser A, Nahshoni E, Weizman A, Leibovici L. Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2006;91:2592- 2599.
30. 4 monotherapy in patients with hypothyroidism, a doubleblind, randomised cross-over study. Eur J Endocrinol. 2009;161: 895-902.
31. Panicker V, Saravanan P, Vaidya B, et al. Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. J Clin Endocrinol Metab. 2009;94:1623-1629.
32. Kim BW, Bianco AC. For some, L-thyroxine replacement might not be enough: a genetic rationale. J Clin Endocrinol Metab. 2009;94: 1521-1523.
33. Salvatore D, Bartha T, Harney JW, Larsen PR. Molecular biological and biochemical characterization of the human type 2 selenodeiodinase. Endocrinology. 1996;137:3308-3315.
34. Gouveia CH, Christoffolete MA, Zaitune CR, et al. Type 2 iodothyronine selenodeiodinase is expressed throughout the mouse skeleton and in the MC3T3-E1 mouse osteoblastic cell line during differentiation. Endocrinology. 2005;146:195-200.
35. Hennemann G, Docter R, Friesema EC, de Jong M, Krenning EP, Visser TJ. Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr Rev. 2001;22:451-476.
36. Celi FS, Zemskova M, Linderman JD, et al. Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, doubleblind, crossover trial of liothyronine versus levothyroxine. J Clin Endocrinol Metab. 2011;96:3466-3474.
37. 3: toward personalized replacement therapy in hypothyroidism? J Clin Endocrinol Metab. 2012;97:2256-2271.
38. Walsh JP, Ward LC, Burke V, et al. Small changes in thyroxine dosage do not produce measurable changes in hypothyroid symptoms, well-being, or quality of life: results of a double-blind, randomized clinical trial. J Clin Endocrinol Metab. 2006;91:2624- 2630.
39. Boeving A, Paz-Filho G, Radominski RB, Graf H, Amaral de Carvalho G. Low-normal or high-normal thyrotropin target levels during treatment of hypothyroidism: a prospective, comparative study. Thyroid. 2011;21:355-360.
40. Sawin CT, Hershman JM, Fernandez-Garcia R, Ghazvinian S, Ganda OP, Azukizawa M. A comparison of thyroxine and desiccated thyroid in patients with primary hypothyroidism. Metabolism. 1978;27:1518-1525.